Code of Massachusetts Regulations › 105 CMR - DEPARTMENT OF PUBLIC HEALTH › Title 105 CMR 300.000 - Reportable Diseases, Surveillance, and Isolation and Quarantine Requirements › Section 300.100 - Diseases Reportable to Local Boards of Health

Current through Register 1525, July 5, 2024
Cases or suspect cases of the diseases listed below shall be
				reported by household members, physicians and other health care providers as
				defined by M.G.L. c. 111, § 1, and other officials designated by the
				Department, by telephone, in writing, by facsimile or other secure electronic
				means, as deemed acceptable by the Department, including transmission from
				electronic health records, immediately, but in no case more than 24 hours after
				diagnosis or identification, to the board of health in the community where the
				case is diagnosed or suspect case is identified. Full demographic, clinical and
				epidemiologic information, as defined by the Department, must be included for
				each report. The local board of health's responsibility, upon receipt of a
				report, is set forth in
				105 CMR
				300.110 and
				300.160.
				Physicians and other health care providers shall also report the diseases
				listed below when identified to be present through point of care testing. If
				diseases primarily ascertained through laboratory testing are reported to the
				Department pursuant to
				105
				CMR 300.170 through
				300.174,
				such report may serve in
lieu
of direct reporting to local
				boards of health:
Amebiasis
Anaplasmosis
Anthrax
Arbovirus infection including, but not limited to, infection
				caused by:
chikungunya virus, dengue, eastern equine encephalitis virus,
				Jamestown Canyon virus, West Nile virus, yellow fever virus, and Zika
				virus
Babesiosis
Botulism
Brucellosis
Campylobacteriosis
Cholera
COVID-19
Creutzfeldt-Jakob disease or variant Creutzfeld-Jakob
				disease
Cryptosporidiosis
Cyclosporiasis
Diphtheria
Ehrlichiosis
Encephalitis, any cause
Foodborne illness due to toxins (including mushroom toxins,
				ciguatera toxins, scombrotoxin, tetrodotoxin, paralytic shellfish toxin and
				amnesic shellfish toxin, staphylococcus enterotoxin, and others)
Giardiasis
Glanders
Group A streptococcus, invasive infection
Group B streptococcus, invasive infection in children younger
				than one year old
Haemophilus influenzae
, invasive
				infection
Hansen's disease (leprosy)
Hantavirus infection
Hemolytic uremic syndrome (HUS)
Hepatitis A
Hepatitis B
Hepatitis C
Hepatitis D
Hepatitis E
Hepatitis syndrome, acute
Influenza
Legionellosis
Listeriosis
Lymphocytic choriomeningitis
Lymphocytic choriomeningitis virus infection
Lyme disease
Malaria
Measles
Melioidosis
Meningitis, bacterial, community-acquired
Meningitis, viral (aseptic) or other infectious
				(non-bacterial)
Meningococcal disease, invasive infection (with N.
				meningitidis)
Mumps
Norovirus infection
Pertussis
Plague
Poliomyelitis
Powassan
Pox virus infections in humans, including variola (smallpox),
				monkeypox, vaccinia, and other orthopox or parapox viruses
Psittacosis
Q Fever
Rabies in humans
Respiratory infection due to a novel or unusual coronavirus,
				causing severe
disease in humans including, but not limited to, severe acute
				respiratory syndrome (SARS) and Middle East respiratory syndrome (MERS).
Reye syndrome
Rickettsialpox
Rocky Mountain spotted fever
Rubella
Salmonellosis
Shigellosis
Shiga toxin-producing organisms isolated from humans, including
				enterohemorrhagic
E. coli
(EHEC)
Streptococcus pneumoniae
, invasive infection
				in individuals younger than 18 years of age Tetanus
Toxic shock syndrome
Trichinosis
Tularemia
Typhoid Fever
Typhus
Varicella (chickenpox)
Vibriosis (non-Cholera)
Viral hemorrhagic fevers including, but not limited to,
				infection caused by Ebola virus, Marburg virus and other filoviruses,
				arenaviruses, bunyaviruses and flaviviruses
Yersiniosis
The following diseases shall also be reported to the local
				board of health. These diseases are often primarily ascertained through
				laboratory testing and reported to the Department pursuant to
				105
				CMR 300.170 through
				300.174.
				If reported to the Department pursuant to
				105
				CMR 300.170 through
				300.175,
				this may serve in
lieu
of direct reporting to local boards of
				health:
Anaplasmosis
Amebiasis
Babesiosis
Campylobacteriosis
Cryptosporidiosis
Cyclosporiasis
Ehrlichiosis
Giardiasis
Glanders
Group A streptococcus, invasive infection
Group B streptococcus, invasive infection in children younger
				than one year old
Haemophilus influenzae
, invasive
				infection
Hantavirus infection
Influenza
Legionellosis
Listeriosis
Lymphocytic choriomeningitis virus infection
Lyme disease
Melioidosis
Noroviruses infection
Psittacosis
Q Fever
Salmonellosis
Shigellosis
Shiga toxin-producing organisms isolated from humans, including
				enterohemorrhagic
E. coli
(EHEC)
Streptococcus pneumoniae
, invasive infection
				in individuals younger than 18 years old
Vibriosis (non-Cholera)
Yersiniosis